TrialAntimicrobial agents and chemotherapy2004

Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1,600/100 milligrams once daily in human immunodeficiency virus-infected patients.

Jennifer Ford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.